Recursion Pharmaceuticals, Inc. (RXRX) vs Teladoc Health, Inc. (TDOC)
A side-by-side comparison of Recursion Pharmaceuticals, Inc. and Teladoc Health, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 2, 2026. Differences are shown without an overall score or investment verdict.
RXRX
Recursion Pharmaceuticals, Inc.
$4.08HealthcareDelayed quote: Oct 2, 2026, 3:40 PM EDT
TDOC
Teladoc Health, Inc.
$5.51HealthcareDelayed quote: Oct 2, 2026, 3:40 PM EDT
Total return — RXRX vs TDOC
growth of $100 · dividends reinvested · last 5yRXRX -77.4% (-25.7%/yr)TDOC -97.1% (-50.6%/yr)RXRX compounded faster over this window
Log scale — wide-divergence pair
RXRX TDOC
RXRX vs TDOC: by the numbers
- •RXRX is the larger company ($2.14B vs $1.00B market cap).
- •Both run net losses; TDOC's is the smaller (-7.13% vs -945.92% net margin).
- •RXRX grew revenue faster over the past five years (45.50% vs 8.85% CAGR).
Metrics side by side
Valuation
| Metric | RXRX | TDOC |
|---|---|---|
| P/S ratio | 39.05 | 0.40 |
| P/B ratio | 2.34 | 0.76 |
| EV / EBITDA | N/A | 12.42 |
| FCF yield | N/A | 22.46% |
Profitability
| Metric | RXRX | TDOC |
|---|---|---|
| Gross margin | -61.96% | 73.53% |
| Operating margin | -867.87% | -6.98% |
| Net margin | -945.92% | -7.13% |
| ROE | -56.71% | -13.54% |
| ROIC | -49.78% | -7.32% |
Growth (annualized)
| Metric | RXRX | TDOC |
|---|---|---|
| Revenue CAGR (5Y) | 45.50% | 8.85% |
| Total return CAGR (5Y) | -28.56% | -46.28% |
Frequently asked
- Which has grown faster, RXRX or TDOC?
- Over the past five years, RXRX grew revenue faster — RXRX at a 45.50% CAGR versus TDOC at 8.85%.
- How have RXRX and TDOC total returns compared?
- Over the past 5 years, RXRX delivered -28.56% and TDOC delivered -46.28% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Recursion Pharmaceuticals ROETeladoc Health ROERecursion Pharmaceuticals operating marginTeladoc Health operating marginRecursion Pharmaceuticals revenue growthTeladoc Health revenue growthRecursion Pharmaceuticals free cash flowTeladoc Health free cash flow
Recursion Pharmaceuticals & Teladoc Health appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 2, 2026.